RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Do SGLT-2 inhibitors exhibit similar cardiovascular benefit in patients having reduced ejection fraction heart failure with type 2 diabetes, prediabetes and normoglycemia?

Do SGLT-2 inhibitors exhibit similar cardiovascular benefit in patients having reduced ejection fraction heart failure with type 2 diabetes, prediabetes and normoglycemia?

Add to Collection
2021 Nov-Dec Others Fist_Author_Year_PM

Full Author : ['Singh, Awadhesh Kumar', 'Singh, Ritu']
Journal Title : Diabetes & metabolic syndrome
Chapter : Section3
Journal Year : 2021
Cited by : Not Available

BACKGROUND AND AIMS: We aimed to know whether SGLT-2 inhibitors (SGLT-2I) exhibit similar cardiovascular (CV) benefit in patients having reduced ejection fraction heart failure (HFrEF) with varying degree of glycemia. METHOD: We meta-analyzed the trial-le.....

Keywords : ["reduce ejection fraction heart failure", "inhibitor exhibit similar cardiovascular benefit", "type diabetes prediabete", "patient", "normoglycemia"]